[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628254":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":38,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":61,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Elazığ Mental Health and Diseases Hospital","OTHER_GOV",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Methamphetamine Use Disorder (MUD)",null,"Adult participants (18-65 years) diagnosed with Methamphetamine Use Disorder according to DSM-5-TR criteria. No intervention was\u002Fwill be assigned by the study protocol. Participants were\u002Fwill be evaluated at baseline and after 6 weeks of routine clinical treatment. Electrocardiogram (ECG) and complete blood count were\u002Fwill be obtained from participants at baseline and after six weeks of follow-up. No psychometric scales were\u002Fwill be administered to this group. Sociodemographic and clinical data were\u002Fwill be recorded for all participants.",{"label":13,"type":10,"description":14,"interventionNames":10},"Methamphetamine-Induced Psychotic Disorder (MP)","Adult participants (18-65 years) diagnosed with Methamphetamine-Induced Psychotic Disorder according to DSM-5-TR criteria. No intervention was\u002Fwill be assigned by the study protocol. Participants were\u002Fwill be evaluated at baseline and after 6 weeks of routine clinical treatment. Electrocardiogram (ECG) and complete blood count were\u002Fwill be obtained from participants at baseline and after six weeks of follow-up. Psychotic symptom severity was\u002Fwill be assessed using the Positive and Negative Syndrome Scale (PANSS). Insight Assessment Scale (IAS) was\u002Fwill be used to measure the insight level. Sociodemographic and clinical data were\u002Fwill be recorded for all participants.",{"label":16,"type":10,"description":17,"interventionNames":10},"Healthy Control (HC)","Healthy control (HC) adult participants (18-65 years) without any current or past psychiatric disorder. No intervention was administered as part of the research protocol. Participants underwent a baseline clinical evaluation and provided a single blood sample for measurement of complete blood count. Sociodemographic and clinical data were recorded for all participants. As of December 15, 2025, the recruitment of HC participants has been completed.",[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Mehmet Hamdi ÖRÜM, MD, Assoc. Prof., Psychiatrist","CONTACT","+905382207558","mhorum@hotmail.com",[25],{"facility":5,"status":26,"city":27,"state":27,"zip":28,"country":29,"countryCode":10,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","Elâzığ","23200","Turkey (Türkiye)",{"type":31,"coordinates":32},"Point",[33,34],39.22321,38.67431,{"lat":34,"lon":33},[37],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Mehmet Hamdi ÖRÜM","Associate Professor, MD, Psychiatrist","100628254","ecg-findings-in-methamphetamine-use-100628254",false,"NCT07459244","ECG Findings in Methamphetamine Use","Electrocardiogram Findings in Methamphetamine Use Disorder and Methamphetamine-Induced Psychotic Disorder: A Prospective Observational Cohort Study","1. For Methamphetamine Use Disorder (MUD) Group:\n\n   \\*Inclusion Criteria:\n   * Diagnosis of MUD according to DSM-5-TR\n   * Medication-free for at least one month prior to admission\n   * Age ≥ 18 years and \\\u003C65 years\n   * Provided informed consent\n\n   For Methamphetamine Use Disorder (MUD) Group:\n\n   \\*Exclusion Criteria:\n\n   • Hypertension\n   * Diabetes mellitus\n   * Chronic kidney disease\n   * Rheumatoid arthritis\n   * Systemic lupus erythematosus\n   * Cardiac illness\n   * Severe neurological disorders\n   * Immunological or systemic illness\n   * Primary psychiatric disorders other than MUD\n   * Alcohol use disorder\n2. For Methamphetamine-Induced Psychotic Disorder (MP) Group:\n\n   \\*Inclusion Criteria:\n   * Diagnosis of MP according to DSM-5-TR\n   * Medication-free for at least one month prior to admission\n   * Age ≥ 18 years and \\\u003C65 years\n   * Provided informed consent\n\n   For Methamphetamine-Induced Psychotic Disorder (MP) Group:\n\n   \\*Exclusion Criteria:\n   * Hypertension\n   * Diabetes mellitus\n   * Chronic kidney disease\n   * Rheumatoid arthritis\n   * Systemic lupus erythematosus\n   * Cardiac illness\n   * Severe neurological disorders\n   * Immunological or systemic illness\n   * Primary psychiatric disorders other than MP\n   * Alcohol use disorder\n3. For Healthy Control Group:\n\n   \\*Inclusion Criteria:\n   * No psychiatric diagnosis\n   * No systemic or immunological illness\n   * Medication-free for at least one month\n   * Age ≥ 18 years and \\\u003C65 years\n   * Provided informed consent\n\n   For Healthy Control Group:\n\n   \\*Exclusion Criteria:\n\n   • Hypertension\n   * Diabetes mellitus\n   * Chronic kidney disease\n   * Rheumatoid arthritis\n   * Systemic lupus erythematosus\n   * Cardiac illness\n   * Severe neurological disorders\n   * Immunological or systemic illness\n   * Primary psychiatric disorders other than schizophrenia\n   * Alcohol\u002Fdrug\u002Fsubstance use",true,"MALE","18 Years","65 Years",{"count":54,"type":55},240,"ESTIMATED","OBSERVATIONAL","This prospective cohort study aims to examine and compare electrocardiogram (ECG) parameters in subjects diagnosed with Methamphetamine Use Disorder (MUD) and Methamphetamine-Induced Psychotic Disorder (MP) during inpatient psychiatric treatment. ECG findings at hospital admission and during remission prior to discharge will be evaluated and compared between groups. The study also aims to determine whether methamphetamine-induced psychosis is associated with greater ECG abnormalities and increased cardiac risk compared to methamphetamine use without psychosis.",[59,60],"Methamphetamine Use Disorder","Methamphetamine Induced Psychosis",[62,59,63,64,65],"Methamphetamine","Methamphetamine-Induced Psychosis","Electrocardiography","Cardiac Risk","2026-03-04",{"date":68,"type":69},"2026-03-09","ACTUAL",{"date":71,"type":69},"2025-04-07",{"date":73,"type":55},"2026-05-11",{"name":5,"class":6},1]